Advertisement
Zydus Lifesciences Limited (ZYDUSLIFE.BO)
BSE - BSE Real Time Price. Currency in INR
Follow
As of 09:07AM IST. Market open.
| Previous Close | 948.35 |
| Open | 949.00 |
| Bid | 967.35 x N/A |
| Ask | 929.40 x N/A |
| Day's Range | 949.00 - 949.00 |
| 52 Week Range | 630.15 - 1,323.90 |
| Volume | |
| Avg. Volume | 53,560 |
| Market Cap | 954.912B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | 22.38 |
| EPS (TTM) | 42.40 |
| Earnings Date | Feb 07, 2025 - Feb 11, 2025 |
| Forward Dividend & Yield | 3.00 (0.32%) |
| Ex-Dividend Date | Jul 26, 2024 |
| 1y Target Est | 1,081.28 |
Simply Wall St.Owning 75% inZydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future
Key Insights Insiders appear to have a vested interest in Zydus Lifesciences' growth, as seen by their sizeable ownership 75% of the company is held by a single shareholder (Pankaj Patel) Institutional ownership in Zydus Lifesciences is 14%
Business WireZydus launches Mirabegron Extended-Release Tablets in the US
AHMEDABAD, India, April 22, 2024--Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.